webinar register page

Webinar banner
Technology’s Role in Overcoming a Disrupted Life-Sciences Reality - An Axendia "Straight from the Source" Webinar Presented by MasterControl

01:01:00

Apr 14, 2020 10:22 AM

Webinar logo
* Required information
Loading

Speakers

Hugo Felix
Director, Device Standards and Compliance @Pfizer
Hugo Félix is currently Director, Device Standards and Compliance for Pfizer’s Medical Device and Combination Products. He has responsibility for medical device standards monitoring, corporate policy as well as standards impact assessment and solution implementation. Hugo has over 25 years of experience with medical device quality in manufacturing, development and quality systems in Medical Devices, Pharmaceuticals, In Vitro Diagnostics and Health & Wellness devices. He has held roles with companies such as Johnson & Johnson, Roche Pharmaceuticals and Siemens Healthcare Diagnostics as well as startup experience. Hugo has a Bachelor of Science degree in Mechanical Engineering from Massachusetts Institute of Technology (MIT). He has held multiple industry certifications from ASQ including Certified Biomedical Auditor, Certified Quality Engineer, Certified Quality Auditor, and Certified Reliability Engineer.
Sandra K. Rodriguez
Market Analyst @Axendia Inc.
Sandra is a Market Analyst at Axendia, an analyst firm providing trusted advice to Life-Science Executives on Business, Technology and Regulatory issues. Sandra has fifteen years of experience working within the FDA-regulated industries, including sales, marketing and market research projects. She has authored numerous articles and white papers on technology trends and their impact on the Life Sciences Industry. Sandra served six years in the US Army Reserve.
Daniel R. Matlis
President @Axendia Inc.
Dan has almost three decades of industry experience spanning the Health-Science value chain. He has been an active member in FDA’s Case for Quality Initiative since 2014 and has presented Axendia’s research findings to industry executives and the FDA officials. He is a frequent lecturer at Industry events and has published numerous research reports and articles on key issues facing the Life-Sciences and Healthcare industries.